Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Diagnostics (Basel, Switzerland)|February 25, 2022
A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal CarcinomaKarim Gourari, Julien Catherine, Soizic Garaud, et al.
IEEE Transactions on Neural Networks and Learning Systems|September 8, 2021
How Frequency Injection Locking Can Train Oscillatory Neural Networks to Compute in PhaseAida Todri-Sanial, Stefania Carapezzi, Corentin Delacour, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumoursAhmad Awada, Alain Hendlisz, Olaf Christensen, et al.
BJU International|December 16, 2010
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinomaPatrick Schöffski, Jorge A Garcia, Walter M Stadler, et al.
Prostate Cancer and Prostatic Diseases|June 10, 2021
Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancerNieves Martinez Chanza, Brandon Bernard, Philippe Barthelemy, et al.
Journal of Clinical Pharmacology|January 7, 2011
Safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors: results of a phase 1 trialAhmad Awada, Thierry Gil, Nicolas Whenham, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2016
Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trialPhilippe Aftimos, Laura Polastro, Lieveke Ameye, et al.
BJU International|December 17, 2016
Clinical impact of <sup>68</sup> Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approachSimone Albisinni, Carlos Artigas, Fouad Aoun, et al.
Acta Gastro-Enterologica Belgica|March 9, 2007
Imatinib for the treatment of patients with unresectable or metastatic malignant KIT-positive gastrointestinal stromal tumours: an open-label Belgian trialHans Prenen, Herlinde Dumez, Cristiana Stefan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986Maria De Santis, Joaquim Bellmunt, Graham Mead, et al.
Pageof 5